Merck & Co., Inc., the New Jersey-based pharmaceutical company, announced Tuesday May 26 they had agreed to purchase Themis Bioscience. The deal, executed for an undisclosed cash sum, will bring ...

The update builds on Themis V2, a life-sized humanoid introduced in April 2025 that the company described as one of the most agile robots in its class. Westwood Robotics has unveiled Themis Gen 2.5, a ...

Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an experienced ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...

Perhaps it is not surprising that inviting people to reconsider the merits of disliked speech features generates a bit of controversy. After all, we are nothing if not wedded to our firm beliefs about ...

1st May 2026: We added a new Tears of Themis code. Tears of Themis is a popular free-to-play visual novel from Genshin Impact makers HoYoverse. Blending dating sim and detective games, it mashes up ...

The MCV test measures the size of your red blood cells. A normal MCV for adults is between 80 and 100 femtoliters. MCV levels can indicate conditions like anemia or vitamin deficiency. The Mean ...

For those of us who can remember the days of eating a mall pretzel while clad in the inexplicable combo of Ugg boots, jean miniskirt and a polo shirt (always with several layers of tank tops ...

Gujarat Themis Biosyn shares spiked 14.3 per cent in trade on BSE, logging an intra-day high at ₹369.4 per share. At 11:58 AM, Gujarat Themis Biosyn’s share price was trading 14.31 per cent higher at ...

Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale beyond its traditional base. The company has signed an agreement to acquire ...

Mumbai-based Gujarat Themis Biosyn Ltd. (GTBL) has informed exchanges that it has signed an asset purchase agreement with Sanofi to acquire a portfolio of anti-tuberculosis (TB) and anti-infective ...